Mexico vs Rwanda: HIV/AIDS deaths averted by antiretroviral therapy
Mexico
12,379 deaths
in 2024
Rwanda
13,299 deaths
in 2024
Mexico rank
19th
Rwanda rank
18th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Mexico
- Rwanda
How they compare
Rwanda currently reports 13,299 deaths against 12,379 deaths in Mexico, a difference of 920 deaths.
That makes Rwanda's figure about 1.1 times Mexico's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Rwanda ahead.
Mexico ranks 19th and Rwanda ranks 18th of 157 countries.
Across the 4 decades both report, Mexico averaged higher in 1 and Rwanda in 3.
Head to head by decade
| Decade | Mexico | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 379.05 deaths | 0 deaths | 379.05 deaths | Mexico |
| 2000s | 3,660 deaths | 3,990 deaths | 329.6 deaths | Rwanda |
| 2010s | 8,109 deaths | 12,999 deaths | 4,890 deaths | Rwanda |
| 2020s | 11,646 deaths | 13,654 deaths | 2,008 deaths | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Mexico or Rwanda?
- Rwanda, at 13,299 deaths against 12,379 deaths in Mexico as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Mexico and Rwanda?
- 920 deaths, with Rwanda ahead.
- How many years of comparable data are there for Mexico and Rwanda?
- 35 years are reported by both, from 1990 to 2024.
- How do Mexico and Rwanda rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Mexico ranks 19th and Rwanda ranks 18th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.